These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 7531589
1. DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma. Berner A, Waere H, Nesland JM, Paus E, Danielsen HE, Fosså SD. Br J Urol; 1995 Jan; 75(1):26-32. PubMed ID: 7531589 [Abstract] [Full Text] [Related]
2. Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer. Waehre H, Wanderaas EH, Paus E, Fosså SD. Eur Urol; 1992 Jan; 22(1):33-8. PubMed ID: 1385143 [Abstract] [Full Text] [Related]
3. Prognostic significance of antigenic heterogeneity, Gleason grade, and ploidy of lymph node metastases in patients with prostate cancer. Bazinet M, Hamdy SM, Bégin LR, Stephenson RA, Fair WR. Prostate; 1992 Jan; 20(4):311-26. PubMed ID: 1376912 [Abstract] [Full Text] [Related]
9. Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density. Blackwell KL, Bostwick DG, Myers RP, Zincke H, Oesterling JE. J Urol; 1994 Jun; 151(6):1565-70. PubMed ID: 7514689 [Abstract] [Full Text] [Related]
11. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T, Herawi M, Epstein JI, Illei PB. Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [Abstract] [Full Text] [Related]
14. [Discrepancy between the serum levels of gamma seminoprotein and prostate-specific antigen in patients with prostatic neoplasms. Both true or either untrue]. Fujino A, Mukai N, Kawakami T, Yokoyama E, Mashimo S, Endo T, Ishibashi A, Koshiba K, Aoki Y, Itoh H. Nihon Hinyokika Gakkai Zasshi; 1991 Apr; 82(4):541-50. PubMed ID: 1711133 [Abstract] [Full Text] [Related]
16. Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas. Stege R, Grande M, Carlström K, Tribukait B, Pousette A. Clin Cancer Res; 2000 Jan; 6(1):160-5. PubMed ID: 10656445 [Abstract] [Full Text] [Related]
17. Prostate-specific antigen and prostatic acid phosphatase in the detection of early prostate cancer and in the prediction of regional lymph node metastases. Wirth MP, Frohmüller HG. Eur Urol; 1992 Jan; 21(4):263-8. PubMed ID: 1281102 [Abstract] [Full Text] [Related]